保险行业2026年中报综述:利润高增价值稳健_第1页
保险行业2026年中报综述:利润高增价值稳健_第2页
保险行业2026年中报综述:利润高增价值稳健_第3页
保险行业2026年中报综述:利润高增价值稳健_第4页
保险行业2026年中报综述:利润高增价值稳健_第5页
已阅读5页,还剩17页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

表1:上市险企2026年中报业绩概览 5表2:上市险企2026年上半年新准则利源分析 6表3:上市险企EV变动驱动因素分析 7表4:上市险企代理人规模缓慢企稳 9表5:上市险企代理人产能收入数据 10表6:2026上半年银保、个险渠道新单保费情况 表7:上市险企非车保费同比增速情况 14表8:上市险企车险业务综合成本率 15表9:上市险企非车业务综合成本率 15表10:上市险企投资收益拆解(可比口径) 17表上市险企年化净/总/综合投资收益率 19表12:上市险企大类资产配置情况(单位:亿元) 20表13:上市险企非标资产及配置结构(单位:百万元) 21表14:上市险企FVOCI-权益工具/股票规模及占总投资资产比重(亿元) 22表15:2026H1上市险企OCI债权和股权投资收益情况 23一、中报总结:利润高增,价值与投资共振2026年上半年,保险业负债端“成本优化与产品转型”和资产端“长期资金入市、增配3,284亿元,同比+78%,各公二是归母净资产普遍扩张,但偿付能力面临考验。2.562.8%~11.6%ROE推动内生积累,新华保险、中国人寿17.3pct,实现“量质齐升”10.1%,但核心偿付能力充足率降低43.4pct127.6%。三是上半年集团新业务价值保持正增长,3.5%~33.7%,中国人寿领跑,中国太保、NBV的改善。OCI股票+基金占投资资产比重较年初普遍提升FVOCI股票占股票+基金比例FVOCI股票占股票+体现了其在偿付能力充裕下的战略主动性,旨在锁定长期稳定收益。表1:上市险企2026年中报业绩概览单位:百万元中国人寿中国平安中国太保2025H/20252026H同比/较年初2025H/20252026H同比/较年初2025H/20252026H同比/较年初归母净利润40,931134,489228.6%68,04792,58536.1%27,88530,77510.4%归母净资产595,205664,20311.6%1,000,4191,028,0842.8%302,143319,1965.6%ROE归母净资产收益率7.83%21.07%13.2pct7.20%9.00%1.8pct9.60%9.70%0.1pct综合投资收益率(年化)---6.20%4.20%-2.0pct4.80%3.60%-1.2pct核心偿付能力充足率-寿险139.54%156.80%17.3pct123.30%133.80%10.5pct157.00%143.00%-14.0pct集团内含价值EV1,467,8761,614,20710.0%1,504,2881,567,8004.2%613,365636,9383.8%上半年新业务价值NBV28,54638,16733.7%22,33524,84711.2%9,54410,75812.7%(股票+基金)/投资资产16.93%19.16%2.2pct20.33%21.06%0.7pct13.77%14.29%0.5pctFVOCI股票/(股票+基金)18.49%25.80%7.3pct41.53%45.96%4.4pct29.81%28.40%-1.4pct单位:百万元新华保险中国人保中国太平(港元)2025H/20252026H同比/较年初2025H/20252026H同比/较年初2025H/20252026H同比/较年初归母净利润14,79922,79354.0%26,53036,74538.5%6,76412,87390.3%归母净资产111,544123,57810.8%308,991340,13910.1%95,155103,6388.9%ROE归母净资产收益率15.93%18.87%2.9pct9.50%11.20%1.7pct---综合投资收益率6.40%6.40%0.0pct---3.72%5.96%2.2pct核心偿付能力充足率-寿险135.11%126.21%-8.9pct171.00%127.60%-43.4pct143.00%128.00%-15.0pct集团内含价值EV287,840310,3847.8%159,518188,73018.3%280,603303,7078.2%上半年新业务价值NBV6,1826,91611.9%8,7289,0343.5%6,7787,2166.5%(股票+基金)/投资资产21.13%25.54%4.4pct13.33%15.45%2.1pct16.61%18.07%1.5pctFVOCI股票/(股票+基金)9.90%10.66%0.8pct27.82%27.20%-0.6pct25.62%29.20%3.6pct各公司2026年中报 ;注:2025H/2025A的选取:归母净资产、内含价值、(股票+基金)/投资资产、FVOCI股票/(股票+基金)均为2025年数据,对应为较年初变化,其余指标为2025H数据,对应为同比变化;“-”代表财报未披露相关数据。二、盈利与价值分析:投资业绩主导,NBV继续扩容2026NBV变化的逻辑来进行讨论。1、盈利拆分下投资业绩成为主导因素。新准则下进行业绩拆分,上半年权益市场风格分124,841百万元,投资业绩/76.6%67.5%、71.6%,64.2%、58.0%、72.3%(承保财务损失149.2%349.4%的原因所在。表2:上市险企2026年上半年新准则利源分析单位:百万元中国人寿平安寿险(营运利润)太保寿险2025H2026H同比变动2025H2026H同比变动2025H2026H同比变动保险服务业绩及其他14,59438,208161.8%44,84045,8032.1%15,14815,7574.0%保险服务收入106,874112,5255.3%112,119107,156-4.4%42,27443,0731.9%保险服务支出88,20270,442-20.1%67,02761,646-8.0%26,32626,3370.0%保险投资业绩27,777124,841349.4%12,91817,52735.7%7,1008,77723.6%总投资收益净额125,419312,536149.2%---46,74656,11820.0%承保财务损失97,642187,69592.2%---39,64647,34119.4%税前利润42,371163,049284.8%57,75863,3319.6%22,24824,53410.3%净利润41,956136,003224.2%82,525107,51330.3%20,69924,03016.1%保险服务业绩/税前利润34.4%23.4%-11.01pct77.6%72.3%-5.31pct68.1%64.2%-3.86pct保险投资业绩/税前利润65.6%76.6%11.01pct22.4%27.7%5.31pct31.9%35.8%3.86pct单位:百万元新华保险人保寿险中国寿险(港元)2025H2026H同比变动2025H2026H同比变动2025H2026H同比变动保险服务业绩及其他6,6778,66229.7%4,8004,441-7.5%10,67510,7530.7%保险服务收入24,75326,4426.8%14,01813,611-2.9%32,25033,9515.3%保险服务支出16,24215,570-4.1%8,2977,901-4.8%20,97422,0415.1%保险投资业绩9,54117,96188.3%2,47011,201353.5%-1,8167,775-总投资收益净额43,38056,10329.3%18,25131,27071.3%---承保财务损失33,83938,14212.7%15,78120,06927.2%---税前利润16,21826,62364.2%7,27015,642115.2%8,86018,528109.1%净利润14,80122,79654.0%6,86213,56297.6%8,27816,682101.5%保险服务业绩/税前利润41.2%32.5%-8.63pct66.0%28.4%-37.63pct120.5%58.0%-62.46pct保险投资业绩/税前利润58.8%67.5%8.63pct34.0%71.6%37.63pct-20.5%42.0%62.46pct各公司2026年中报 ;注;“-”代表财报未披露相关数据。2、NBVEV增速明显更平稳。EV2026H1EV3.8%~18.3%,中国人保(+18.3%)、中国人寿(+10.0%)EV变动看,NBVEV的2.3%~2.7%2.9%~3.0%;投资回报偏差方面,中国人寿+3.3%、新华保险+2.0%+0.4%+0.9%表3:上市险企EV变动驱动因素分析2018A2019A2020A2021A2022A2023A2024A2025A2026H预期回报中国人寿8.2%8.4%8.1%7.9%7.5%6.8%7.9%5.4%2.9%中国平安9.1%9.4%8.7%8.5%8.1%7.8%6.9%6.1%2.9%中国太保9.7%9.3%9.1%9.2%8.6%8.2%7.2%6.4%3.0%新华保险9.2%9.2%8.8%8.0%7.7%7.6%6.6%6.0%2.9%NBV中国人寿6.7%7.4%6.2%4.2%3.0%3.0%2.7%3.3%2.6%中国平安14.6%12.4%6.5%4.6%3.3%3.6%3.4%4.4%2.7%中国太保12.7%9.5%5.8%3.9%2.4%2.8%3.3%4.4%2.3%新华保险8.0%5.6%4.5%2.5%0.9%1.2%2.5%3.8%2.4%营运偏差中国人寿0.0%0.0%0.1%-0.6%0.0%-0.1%0.1%0.1%0.3%中国平安2.8%0.6%-1.5%-2.0%-0.2%0.5%1.8%1.7%0.8%中国太保-0.1%1.5%-0.2%-1.4%-0.1%0.7%1.3%0.4%0.1%新华保险2.0%0.9%1.9%0.0%1.1%1.1%1.9%2.7%1.5%投资偏差中国人寿-6.1%4.0%2.6%-0.3%-8.1%-6.0%5.1%4.8%3.3%中国平安-2.5%5.2%-0.8%-3.0%-4.6%-3.3%2.6%3.6%0.4%中国太保0.1%2.0%2.1%-0.4%-4.9%-5.5%6.6%-0.6%0.9%新华保险-3.8%4.8%4.3%-0.6%-6.9%-5.6%8.1%2.5%2.0%股息/注资中国人寿-1.6%-0.6%-3.0%-1.7%-1.5%-1.1%-1.4%-1.4%-1.2%中国平安-6.3%-7.9%-6.5%-2.5%-3.9%-4.1%-2.9%-4.8%-2.6%中国太保-3.9%-4.9%-5.5%-3.0%0.6%-1.5%-1.7%-1.7%-1.9%新华保险-1.1%-1.4%-2.1%-1.8%-1.7%-1.3%-1.7%-3.2%-2.2%各公司2018-2025年年报,各公司2026年中报3、NBV5.2%~33.7%得益于分红险转型以及报行合一压降费用等因素影响,26H1VIF打平成本率,2.39%、2.14%、2.16%、2.98%、3.33%,NBV1.05%、1.03%、0.99%、1.67%、2.05%,(65号文)2.0政策约束,监管要求银保四项费用分NBV贡献占比有所回落、个险贡献回升,推动险企从短期费用驱动转向长期渠道价值比拼。图1:26H1上市险企打平成本率下降各公司2026年中报,各公司2025年报图2:上市险企NBV增速 图3:上市险企银保NBV贡献占比各公司2015-2025年年报,各公司2026年中报, 研发中 各公司2019-2025年年报,各公司2026年中报, 研发中心 心三、负债端总结:人身险渠道再平衡,财险量稳价优人身险:个险修复,渠道结构再平衡20261、代理人规模企稳,人均产能提升。2026年上半年,中国人寿、中国平安、中国太保、5142万人,较年初+0.1%2020年以来10+.%、中国太平17.2万(+3.0%)、中国太保18.5万(+2.2%)实现正增长,中国平安32.5万(-7.4%)12.8万(-3.8%)NBV5.54万元同比+14.1%55.5%10,418元同比+5.3%;新华保险月2.2万元同比+31.7%20.7%(+2.1pct)。表4:上市险企代理人规模缓慢企稳代理人(万人)2017A2018A2019A2020A2021A2022A2023A2024A2025A2026H中国人寿157.8143.9161.3137.882.066.863.461.558.761.0中国平安138.6141.7116.7102.460.044.534.736.335.132.5中国太保87.484.779.074.952.527.921.018.818.118.5新华保险34.837.050.760.638.919.715.513.613.312.8中国人保25.624.639.141.418.69.78.98.37.7-中国太平38.451.338.638.138.540.823.522.616.717.2合计482.6483.2485.4455.2290.5209.5167.0161.1149.6152.7相比年初增速2017A2018A2019A2020A2021A2022A2023A2024A2025A2026H中国人寿5.6%-8.8%12.1%-14.6%-40.5%-18.5%-5.1%-3.0%-4.6%3.9%中国平安24.8%2.3%-17.7%-12.3%-41.4%-25.9%-22.0%4.6%-3.3%-7.4%中国太保33.8%-3.1%-6.7%-5.2%-29.9%-46.9%-24.7%-10.5%-3.7%2.2%新华保险6.1%6.3%37.0%19.5%-35.8%-49.4%-21.3%-12.3%-2.2%-3.8%中国人保35.2%-4.0%59.3%5.9%-55.1%-47.6%-8.6%-6.7%-7.2%-中国太平46.7%33.5%-24.8%-1.1%1.0%6.0%-42.5%-3.7%-26.1%3.0%合计19.5%0.1%0.4%-6.2%-36.2%-27.9%-20.3%-3.5%-7.1%0.1%数据来源:各公司2017-2025年年报,各公司2026年中报表5:上市险企代理人产能收入数据中国平安2021A2022A2023A2024A2025A2026H人均NBV(元/年)39,03147,63990,285101,27180,37555,353同比增速-4.1%22.1%89.5%12.2%17.2%14.1%代理人活动率47.0%50.8%53.3%52.8%50.4%55.5%月人均收入(元)5,7587,0519,81310,3959,29910,418同比增速-0.6%22.5%39.2%5.9%-10.5%5.3%中国太保2021A2022A2023A2024A2025A2026H月人均新单保费(元)4,6386,84412,83716,73420,392-同比增速42.3%47.6%51.6%30.4%21.9%-月人均举绩率-63.4%67.9%68.3%--同比变动--4.5pct0.4pct--核心人力月人均FYC(元)-4,1366,4136,8686,696-同比增速--55.1%7.1%-2.5%-新华保险2021A2022A2023A2024A2025A2026H月均人均综合产能(元)2,7253,2376,2948,10011,20022,000同比增速4.1%18.8%94.4%28.7%38.3%31.7%月均合格人力(万人)9.14.52.71.62.22.7同比增速-28.9%-50.5%-40.0%-37.5%7.2%月均合格率19.1%15.0%15.8%10.9%16.5%20.7%同比变动-4.7-4.10.8-5.62.1各公司2021-2025年年报,各公司2026年中报 ;注:“-”代表财报未披露相关数据。图4:上市险企月人均新单产能 图5:上市险企月人均NBV各公司2011-2025年年报,各公司2026年中报, 研发中心

各公司2011-2025年年报,各公司2026年中报, 研发中心说明:此处为估算值,可能与实际值存在偏差,仅供参考。 说明:此处为估算值,可能与实际值存在偏差,仅供参考。26506H1+93%、中国人寿+16.1%+17.5%-25.9%-20.2%23.1%26.8%34.2%、新48.4%60.4%38.4%+16.6%、中国平安+21.8%+28.4%+24.0%+9.1%+7.5%,随着代理人队伍企稳和产能提升,个险渠道新单保费实现恢复性增长。图6:26H1银保渠道价值率保持高位各公司2019-2022,2024-2025年年报,各公司2026年中报表6:2026上半年银保、个险渠道新单保费情况单位:百万元中国人寿中国平安中国太保2025H2026H同比变动2025H2026H同比变动2025H2026H同比变动银保新单35,87341,661+16.1%22,87538,722+69.3%29,03821,531-25.9%银保新单/总新单22.2%23.1%+4.0%20.5%26.8%+30.7%45.0%34.2%-23.9%个险新单73,88586,183+16.6%75,60392,069+21.8%22,62229,045+28.4%个险新单/总新单45.8%47.9%+4.5%67.9%63.8%-6.0%35.0%46.2%+31.7%单位:百万元新华保险中国人保中国太平(港元)2025H2026H同比变动2025H2026H同比变动2025H2026H同比变动银保新单24,93919,902-20.2%29,67419,007-35.9%10,90412,810+17.5%银保新单/总新单58.8%48.4%-17.6%71.9%60.4%-16.0%36.3%38.4%+5.8%个险新单15,06418,675+24.0%10,01210,928+9.1%18,63120,031+7.5%个险新单/总新单35.5%45.4%+28.0%24.3%34.7%+43.2%62.0%60.1%-3.1%各公司2025-2026年中报3、储蓄产品仍是主流,产品结构以分红险转型为主线。保障型产品非刚需属性下增长乏(图7:中国人寿及新华保险长期健康险/保障型新单增长疲弱 图8:长期健康险/保障型新单占总新单比重持续下降

2018-20252026年中报,

发中心

各公司2018-2025年年报各公司2019-2026年中报, 研注:平安自2023H以来已不再披露相关数据4、保单继续率保持高位。随着代理人质量优化、承保管控趋严,上市险企保单继续率维持高位:13个月继续率方面,中国人寿、中国平安、中国太保、新华保险、中国人保分93.5%、97.3%、96.8%、97.5%、95.5%,25个月继续率方面,中国人寿、中国平90.3%、95.8%、94.8%、93.6%、95.0%,业务品质持续处于较好水平,为价值的兑现提供支撑。图9:2026H1上市险企13个月保单继续率维持高位 图10:2026H1上市险企25个月保单继续率维持高位

2018-20252026年中报,

各公司2018-2025年中报和年报,各公司2026年中报,说明:中国人寿为14个月保单继续率。 说明:中国人寿为26个月保单继续率。财产险:保费平稳,综合成本率显著优化财险保费平稳增长,成本率优化明显。2026上半年整体财险原保费收入同比,太平+5.9%>平安+4.0%>太保+1.4%>人保+1.3%,上半年头部险企车险综合成本率显著改善,非车业务分险种表现分化,承保盈利能力整体提升。120261.3%-5.9%图上半年新车销量增长放缓(万辆) 图12:2026上半年新能源车销量保持较高增速(万辆) 2、非车业务增速有所分化。2026H1人保财险非车分险种:责任险+10.8%、意外伤害及健康险+6.1%较好,企业财产险-0.5%、农险-1.4%相对承压;太保产险健康险+10.4%、责任险+6%-14%-.%+.%+05%、非水险+6.1%。非车盈利改善仍需关注高赔付险种的费用与赔付变化。20268月国家图13:2026H1上市险企财险保费同比增速分化 图14:2026H1中国平安产险非车保费同比增速更优 各公司2016-2025年年报,各公司2026年中报, 研发中 各公司2026年中报心说明:中国太平财险均为境内业务,下同。表7:上市险企非车保费同比增速情况人保财险2022A2023H12023A2024H12024A2025H12025A2026H1企业财产险3.8%5.2%7.0%5.4%2.0%5.7%4.4%-0.5%责任险1.9%8.9%1.3%3.2%9.9%1.3%1.7%10.8%意外伤害及健康险10.3%5.2%3.6%5.7%9.7%7.9%6.4%6.1%货运险0.3%-----1.9%-平安产险2022A2023H12023A2024H12024A2025H12025A2026H1保证保险10.4%-79.3%-97.0%-182.9%-453.8%---责任保险20.4%14.7%6.6%-0.3%4.4%-4.0%0.1%3.7%意外伤害保险-18.7%--27.4%-20.2%25.6%25.2%-健康保险--36.7%43.5%38.3%22.5%--太保产险2022A2023H12023A2024H12024A2025H12025A2026H1健康险20.0%26.3%18.6%21.4%16.9%-3.8%0.0%10.4%企财险-4.0%7.5%22.6%15.0%11.9%1.6%-21.4%责任险37.1%35.1%31.4%11.8%13.0%3.3%3.9%6.6%农险32.7%33.9%28.8%9.8%8.8%4.7%3.4%-1.6%太平产险2022A2023H12023A2024H12024A2025H12025A2026H1水险-9.8%-5.3%6.2%17.9%11.9%2.1%3.7%30.5%非水险-0.6%14.1%7.5%2.2%3.1%6.6%7.0%6.1%各公司2022-2025年年报,各公司2023-2026年中报 ;注:“-”代表财报未披露相关数据。4、94%~95%202694.5%95.0%95.1%2025“报行合一”政策深化成效显著,图15:26H1财险综合成本率下降明显各公司2012-2025年年报,各公司2026年中报表8:上市险企车险业务综合成本率车险综合成本率2023H12023A2024H12024A2025H2025A2026H人保财险96.70%96.90%96.40%96.80%94.20%95.30%93.50%平安产险97.10%97.70%98.10%98.10%95.50%95.80%94.90%太保产险98.00%97.60%97.10%98.20%95.30%95.60%94.60%车险赔付率2023H12023A2024H12024A2025H2025A2026H人保财险69.70%70.40%71.20%72.60%73.10%73.90%-平安产险-------太保产险70.80%70.60%71.40%73.30%---车险费用率2023H12023A2024H12024A2025H2025A2026H人保财险27.00%26.50%25.20%24.20%21.10%23.60%-平安产险-------太保产险27.20%27.00%25.70%24.90%---各公司2023-2025年中报和年报,各公司2026年中报表9:上市险企非车业务综合成本率人保财险2023H12023A2024H12024A2025H12025A2026H1企业财产险92.0%103.8%99.6%113.4%90.1%101.0%86.7%责任险102.8%107.0%104.1%105.2%103.6%104.5%103.1%意外伤害及健康险98.5%97.7%99.9%99.5%101.8%99.0%99.0%农险91.0%95.8%89.0%97.3%93.9%101.9%98.7%平安产险2023H12023A2024H12024A2025H12025A2026H1保证保险117.7%131.1%106.8%102.2%---责任保险99.5%106.3%98.0%102.7%97.6%106.8%96.8%意外伤害保险-106.0%-99.0%98.4%--企业财产保险89.0%97.7%94.7%--99.4%97.8%健康保险--92.3%95.2%95.9%93.4%89.8%太保产险2023H12023A2024H12024A2025H12025A2026H1健康险101.2%99.2%100.8%104.3%99.3%95.0%98.3%企财险95.3%97.2%94.1%103.8%92.8%94.1%90.5%责任险99.4%100.6%99.4%103.7%99.4%102.3%99.0%农险98.1%98.8%97.8%98.7%98.8%103.2%96.2%各公司2023-2025年中报和年报,各公司2026年中报 ;注:“-”代表财报未披露相关数据。四、资产端梳理:投资收益改善,增配OCI股票是趋势买卖价差收入高增,投资收益率保持稳健上半年权益市场上行,投资收益弹性充分释放。2026H16家上市险企合计实现净投资收益(披露)3,002亿元,同比-2.2%;实现总投资收益(披露)6,826亿元,同比+76.8%,其中买卖价差收入2,268亿元(2025H为591亿元)是核心增量;综合投资收益(计算口径+46.4%,OCI权益公允价值变动-1037亿元对综合收益形成一定FVTPLFVOCI的分类对利润表产生了明显的结构性影响——FVTPLOCI权益的公允价值变动则绕过了利润表,直接体现为净资产的波动。由于各家披露的投资收益率口径存在差异,并不完全可比,下面统一口径,具体方法如下:净投资收益率=(股息收入+利息收入+房地产租金收入+应占联营企业和合营企业收益)/(年初投资资产+半年末投资资产)*2。此处将生息类资产、投资性房地产以及长期股权总投资收益率净投资收益+买卖价差收入+公允价值变动损益+投资资产减值损失年初投资资产+半年末投资资产)*2。此处在净投资收益基础上,将反映在利润表里与资本综合投资收益率总投资收益+OCI-权益工具公允价值变动损益年初投资资产+半年末投资资产(反映在净资产中的OCI-权益投资(包括股票、永续债等权益资产)的市值变动损益计入。进行各项指标进行简单年化处理,统一口径计算的结果如下:2026H1净投资收益率(统一口径)由高到低排序:中国人保3.12%(-0.43pct)>中国太平2.85%(-0.26pct)>中国太保2.80%(-0.20pct)>中国人寿2.69%(-0.09pct)>新华保险2.49%(-0.38pct)>中国平安2.26%(-0.81pct);长端利率下行环境下,上市险企净投资收益率整体呈现小幅回落态势,固收端收益持续承压。2026H1(统一口径6.80%(+1.92pct)6.14%(+0.74pct)5.22%(+2.54pct)>中国太保4.25%(+0.34pct)>中国平安4.06%(+0.87pct),权益资产买卖价差与公允价值变动收益贡献显著,带动各家险企总投资收益同比上行。2026H1(统一口径3.45%(-1.88pct)3.27%(-0.82pct),中国人寿权益兑现与浮表10:上市险企投资收益拆解(可比口径)单位:百万元中国人寿中国平安中国太保2025H2026H同比2025H2026H同比2025H2026H同比平均投资资产6,869,1127,684,90311.9%5,966,9426,550,4569.8%2,829,5933,106,4859.8%净投资收益-披露96,067103,0247.2%92,82378,021-15.9%42,56742,7680.5%净投资收益-计算95,391103,3908.4%91,70874,037-19.3%42,42243,4542.4%其中:利息收入74,68676,4572.4%---29,06130,1233.7%其中:股息分红收入13,92218,379---13,19512,220其中:投资性房地产租金收入77-6-107.8---311425其中:应占联营企业和合营企业收益6,7068,560-1,115-3,984257.3-145686-573.1买卖价差收入30,37475,507148.62,99260443760.57,01820,725195.3公允价值变动损益1,029135,8355,8561,726-70.5投资资产减值损失36167363.9%401-1,513-477.3%-10117-1270%总投资收益-披露127,506314,504146.7%96,216136,94242.3%56,88966,02216.1%总投资收益-计算126,830314,899148.3%95,101229,447141.3%55,28666,02219.4%其他权益工具投资公允价值变动7,152-49,343-789.9%64,072-19,907-131.1%2,518-15,222-704.5%综合投资收益-披露---157,809117,373-25.6%---综合投资收益-计算131,938265,556101.3%159,173209,54031.6%57,80450,800-12.1%净投资收益率-统一口径2.78%2.69%-0.09pct3.07%2.26%-0.81pct3.00%2.80%-0.20pct总投资收益率-统一口径3.69%8.20%4.50pct3.19%4.06%0.87pct3.91%4.25%0.34pct综合投资收益率-统一口径3.90%6.91%3.01pct5.34%3.45%-1.88pct4.09%3.27%-0.82pct单位:百万元新华保险中国人保中国太平(港元)2025H2026H同比2025H2026H同比2025H2026H同比平均投资资产1,670,9421,871,54112.0%1,701,2151,949,67914.6%1,622,6911,837,28013.2%净投资收益-披露23,46023,332-0.5%30,32430,5390.7%25,26826,2153.7%净投资收益-计算23,91523,261-2.7%30,22930,4560.8%25,26826,2153.7%其中:利息收入23,14321,415-7.5%18,16917,964-1.1%19,89621,0195.6%其中:股息分红收入3,5714,84335.6%3,9094,07955.5%其中:投资性房地产租金收入1341350.7%31036116.5%392390-0.6%其中:应占联营企业和合营企业收益6381,711168.2%8,1797,288-10.9%1,071728-32.0%买卖价差收入11,01238,234239.4%8,72918,560112.6%-1,22311,825-1066%公允价值变动损益10,230-4,380-142.8%2,50114,085463.2%-2,3769,745-510.1%投资资产减值损失-52339-679846.3%81166106.4%总投资收益-披露45,28857,52527.0%41,47866,37260.0%21,74947,952120.5%总投资收益-计算45,10557,45425.5%41,62163,19951.8%21,74947,952120.5%其他权益工具投资公允价值变动2,092-3,845-283.8%281-8,523-3133.1%2,468-8,014-424.7%综合投资收益-披露48,04055,03914.6%------综合投资收益-计算47,19753,60911.8%41,90254,67630.5%24,21739,93864.9%净投资收益率-统一口径2.86%2.49%-0.38pct3.55%3.12%-0.43pct3.11%2.85%-0.26pct总投资收益率-统一口径5.40%6.14%0.74pct4.88%6.80%1.92pct2.68%5.22%2.54pct综合投资收益率-统一口径5.65%5.73%0.08pct4.91%5.93%1.01pct2.98%4.35%1.36pct各公司2025-2026年中报 ;注:“-”代表财报未披露相关数据。从披露的投资收益率结果看,2026年上半年净投资收益率(NII)受利率下行影响普遍回TPL买卖价差大幅提升普遍改善,综合投资收益率(CII)受OCI1)NII:人保3.4%(简单年化,-0.4pct)>太保3.0%(简单年化,-0.4pct)>太平2.85%(年化,-0.26pct)>2.8%(简单年化,-0.8pct)2.6%(年化,-0.4pct)TIT4%(+.c)>新华7年化+8pc>国寿.8%(年化,+29c)>太平2%(年化,同比+.3pc)>太保8%(简单年化,+0.2pct)。权益市场上行是总投资收益率改善的主因。FVOCI债券+.4pc>平安2%-0pc)>太保6%(-.pct。OCIOCIOCI股票配置差异明显OCI股票占比来看,平安最高(46.0%),远超其他险企。表11:上市险企年化净/总/综合投资收益率净投资收益率2021A2022H12022A2023H12023A2024H12024A2025H2025A2026H1中国人寿4.33%4.38%4.15%4.00%3.78%3.77%3.03%2.78%--中国平安3.80%4.60%3.90%4.70%3.50%4.20%3.30%3.60%3.70%2.80%中国太保4.10%4.50%3.90%4.30%4.00%4.00%3.60%3.40%3.40%3.00%新华保险4.50%4.30%4.70%4.60%3.40%3.40%3.20%3.00%2.80%2.60%中国人保4.80%4.80%4.90%5.10%4.40%4.50%3.80%3.80%3.60%3.40%中国太平4.11%4.07%4.05%4.02%3.63%3.56%3.47%3.11%-2.85%总投资收益率2021A2022H12022A2023H12023A2024H12024A2025H2025A2026H1中国人寿5.69%4.98%4.21%3.94%3.41%2.68%3.59%3.29%6.09%5.58%中国平安3.50%4.00%3.10%2.50%3.40%3.00%3.50%3.78%3.83%-中国太保5.00%5.70%3.90%4.20%4.00%2.60%5.40%4.60%5.70%4.80%新华保险6.50%5.90%4.20%4.30%3.70%1.80%4.80%5.90%6.60%6.70%中国人保6.70%5.80%5.50%4.60%4.90%3.30%4.10%5.20%5.70%7.40%中国太平6.31%5.39%3.35%3.31%3.89%2.66%5.27%2.68%-5.21%综合投资收益率2021A2022H12022A2023H12023A2024H12024A2025H2025A2026H1中国人寿-4.87%-1.92%4.23%3.23%----中国平安-3.39%-2.34%4.10%3.60%4.20%6.20%6.30%4.20%中国太保-4.83%-2.11%4.20%2.70%6.00%4.80%6.10%3.60%新华保险-4.81%-1.83%4.70%2.58%6.50%6.40%5.00%6.40%中国人保-5.57%-1.95%-3.96%--5.48%-中国太平---2.35%5.92%5.01%11.16%3.72%-5.96%各公司2021-2025年年报,各公司2022-2026年中报 ;注:“-”代表财报未披露相关数据。股票+基金占比提升,非标持续压降1、从大类资产配置来看,A股五家上市险企普遍增配股票和基金资产。上半年利率低位与权益市场回暖背景下,各家提升权益配置弹性:2026H1股票+基金占投资资产比重为较年初较年初14.3%较年初+.pc55较年初+4pc81+.pct、15.5%(较年初+2.1pct);债券占比总体稳定,新华保险定存占比明显下降。表12:上市险企大类资产配置情况(单位:亿元)中国人寿2024A2025H2025A2026H较26年初变动2024A占比2025H占比2025A占比2026H占比定存4,3854,5724,1874,4576.4%6.6%6.4%5.6%5.6%债券39,03142,05842,57945,3406.5%59.0%59.0%57.4%57.1%股基8,0769,70812,57215,22221.1%12.2%13.6%16.9%19.2%其他14,61914,93214,89914,442-3.1%22.1%20.9%20.1%18.2%合计66,11171,27274,23779,4617.0%100.0%100.0%100.0%100.0%中国平安2024A2025H2025A2026H较26年初变动2024A占比2025H占比2025A占比2026H占比定存2,4463,0473,2663,65812.0%4.3%4.9%5.0%5.5%债券35,34637,70635,72536,3341.7%61.7%60.8%55.0%55.0%股基6,7478,58113,19713,9205.5%11.8%13.8%20.3%21.1%其他12,77612,69112,71112,197-4.0%22.3%20.5%19.6%18.5%合计57,31462,02564,90066,1101.9%100.0%100.0%100.0%100.0%中国太保2024A2025H2025A2026H较26年初变动2024A占比2025H占比2025A占比2026H占比定存1,7381,7821,8732,0217.9%6.4%6.1%6.2%6.4%债券16,42218,26018,55719,4965.1%60.1%62.4%61.0%61.4%股基3,1743,4994,1874,5348.3%11.6%12.0%13.8%14.3%其他6,0105,7065,7835,679-1.8%22.0%19.5%19.0%17.9%合计27,34529,24730,40031,7304.4%100.0%100.0%100.0%100.0%新华保险2024A2025H2025A2026H较26年初变动2024A占比2025H占比2025A占比2026H占比定存2,8253,3312,9402,270-22.8%17.3%19.4%16.0%11.9%债券8,4958,6739,1409,7516.7%52.1%50.6%49.6%51.3%股基3,0713,1943,8904,85824.9%18.9%18.6%21.1%25.5%其他1,9031,9272,4422,140-12.4%11.7%11.2%13.3%11.3%合计16,29417,12518,41219,0193.3%100.0%100.0%100.0%100.0%中国太平2024A2025H2025A2026H较26年初变动2024A占比2025H占比2025A占比2026H占比定存6837647858467.7%4.4%4.5%4.5%4.4%债券11,63512,87713,26814,3047.8%74.5%76.5%76.1%73.7%股基2,0352,1312,8853,50921.6%13.0%12.7%16.6%18.1%其他1,2681,06149375753.6%8.1%6.3%2.8%3.9%合计15,62116,83317,43119,41511.4%100.0%100.0%100.0%100.0%中国人保2024A2025H2025A2026H较26年初变动2024A占比2025H占比2025A占比2026H占比定存1,2661,2521,2741,3425.4%7.7%7.1%6.7%6.7%债券8,0388,7489,1809,8197.0%49.0%49.7%48.3%49.1%股基1,4691,8822,5353,08721.8%8.9%10.7%13.3%15.5%其他5,6455,7256,0275,729-4.9%34.4%32.5%31.7%28.7%合计16,41817,60719,01619,9775.1%100.0%100.0%100.0%100.0%各公司2024-2025年年报,各公司2025-2026年中报2、非标市场逐渐落幕,上市险企整体继续压降非标资产配置比例。从规模看,2026H19,088亿、4,444亿、2,589亿、959亿、2,444亿元,除新华保险(较年初+11.4%)外普遍延续压降;从6.7%8.2%、5.0%12.2%,新华保险非标固收/权益分项未披露(以合计列示)。表13:上市险企非标资产及配置结构(单位:百万元)非标固收2024A2025H2025A2026H较26年初变动2024A占比2025H占比2025A占比2026H占比中国人寿523,721528,222519,517502,707-3.2%7.9%7.4%7.0%6.3%中国平安366,629345,381323,452284,332-12.1%6.4%5.6%5.0%4.3%中国太保336,824289,161269,572240,209-10.9%12.3%9.9%8.9%7.6%新华保险46,56424,78913,330--2.8%1.4%0.7%-中国人保184,804173,186180,641156,313-13.5%11.3%9.8%9.5%7.8%非标权益2024A2025H2025A2026H较26年初变动2024A占比2025H占比2025A占比2026H占比中国人寿461,452454,818419,143406,141-3.1%7.0%6.4%5.6%5.1%中国平安170,311163,645160,612160,063-0.3%3.0%2.6%2.5%2.4%中国太保20,79516,00623,11018,695-19.1%0.8%0.5%0.8%0.6%新华保险48,56454,25872,710--3.0%3.2%3.9%-中国人保75,71487,36166,57888,071+32.3%4.6%5.0%3.5%4.4%非标合计2024A2025H2025A2026H较26年初变动2024A占比

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论